Mechanistic insights into the translocation of full length HIV-1 Tat across lipid membranes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1808, Issue 11, 2011, Pages 2685-2693

  Boll, Annegret ^a   Jatho, Aline ^a   Czudnochowski, Nadine ^b   Geyer, Matthias ^b   Steinem, Claudia ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Arginine rich motif; Cell penetrating peptide; Fluorescence microscopy; Giant unilamellar vesicle; Protein membrane interaction; Transactivator of transcription

Indexed keywords

2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; CYSTEINE; PROLINE; TRANSACTIVATOR PROTEIN; TRYPTOPHAN;

ARTICLE; BIOACCUMULATION; CELL VACUOLE; CHANNEL GATING; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID MEMBRANE; MEMBRANE TRANSPORT; MOLECULAR SIZE; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTEIN TRANSPORT; TRANSPORT KINETICS;

MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLCHOLINES; PROTEIN TRANSPORT; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; UNILAMELLAR LIPOSOMES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052262557     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2011.07.030     Document Type: Article

References (54)

1. M.C.D.G. Huigen, W. Kamp, and H.S.L.M. Nottet Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection Eur. J. Clin. Invest. 34 2004 57 66 (Pubitemid 38221740)
2. K.A. Jones, and B.M. Peterlin Control of RNA initiation and elongation at the HIV-1 promotor Annu. Rev. Biochem. 63 1994 717 743 (Pubitemid 24218647)
3. K. Strebel Virus-host interactions: role of HIV proteins Vif, Tat and Rev AIDS 17 2003 25 34
4. B. Ensoli, G. Barillari, S.Z. Salahuddin, R.C. Gallo, and F. Wong-Staal Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients Nature 345 1990 84 86
5. H. Xiao, C. Neuveut, H.L. Tiffany, M. Benkirane, E.A. Rich, P.M. Murphy, and K.T. Jeang Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1 Proc. Natl. Acad. Sci. USA 97 2000 11466 11471
6. J.E. King, E.A. Eugenin, C.M. Buckner, and J.W. Berman HIV tat and neurotoxicity Microbes Infect. 8 2006 1347 1357 (Pubitemid 43842005)
7. S. Hwang, N. Tamilarasu, K. Kibler, H. Cao, A. Ali, Y.H. Ping, K.T. Jeang, and T.M. Rana Discovery of a small molecule Tat-trans-activation- responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication J. Biol. Chem. 278 2003 39092 39103 (Pubitemid 37221813)
8. A. Vendeville, F. Rayne, A. Bonhoure, N. Bettache, P. Montcourrier, and B. Beaumelle HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses Mol. Biol. Cell 15 2004 2347 2360 (Pubitemid 38580651)
9. G. Tunnemann, R.M. Martin, S. Haupt, C. Patsch, F. Edenhofer, and M.C. Cardoso Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells FASEB J. 20 2006 1775 1784 (Pubitemid 44933791)
10. R. Fischer, M. Fotin-Mleczek, H. Hufnagel, and R. Brock Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides ChemBioChem 6 2005 2126 2142
11. M.C. Morris, S. Deshayes, F. Heitz, and G. Divita Cell-penetrating peptides: from molecular mechanisms to therapeutics Biol. Cell 100 2008 201 217 (Pubitemid 351517084)
12. V.P. Torchilin Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 90 2008 604 610
13. F. Heitz, M.C. Morris, and G. Divita Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br. J. Pharmacol. 157 2009 195 206
14. P. Lundberg, and Ü. Langel A brief introduction to cell-penetrating peptides J. Mol. Recognit. 16 2003 227 233 (Pubitemid 37231690)
15. V. Sebbage Cell-penetrating peptides and their therapeutic applications Biosci. Horiz. 2 2009 64 72
16. J. Howl, I.D. Nicholl, and S. Jones Cell-penetrating peptides. The many futures for cell-penetrating peptides: how soon is now? Biochem. Soc. Trans. 35 2007 767 769 (Pubitemid 47310364)
17. P.E.G. Thoren, D. Persson, M. Karlsson, and B. Norden The Antennapedia peptide penetratin translocates across lipid bilayers - the first direct observation FEBS Lett. 482 2000 265 268
18. H. Binder, and G. Lindblom Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes Biophys. J. 85 2003 982 995 (Pubitemid 36909662)
19. K.V.R. Reddy, R.D. Yedery, and C. Aranha Antimicrobial peptides: premises and promises Int. J. Antimicrob. Agents 24 2004 536 547 (Pubitemid 39536106)
20. Y. Tamba, and M. Yamazaki Magainin 2 induced pore formation in the lipid membrane depends on its concentration in the membrane interface J. Phys. Chem. 113 2009 4846 4852
21. Y. Tamba, and M. Yamazaki Single giant unilamellar vesicle method reveals effect of antimicrobial peptide magainin 2 on membrane permeability Biochemistry 44 2005 15823 15833 (Pubitemid 41746913)
22. G. Klocek, T. Schulthess, Y. Shai, and J. Seelig Thermodynamics of melittin binding to lipid bilayers. Aggregation and pore formation Biochemistry 48 2009 2586 2596
23. S. Ohki, E. Marcus, D.K. Sukumaran, and K. Arnold Interaction of melittin with lipid membranes Biochim. Biophys. Acta 1194 1994 223 232 (Pubitemid 24287128)
24. T. Benachir, and M. Lafleur Study of vesicle leakage induced by melittin Biochim. Biophys. Acta 1235 1995 452 460
25. C.E. Dempsey The actions of melittin on membranes Biochim. Biophys. Acta 1031 1990 143 161
26. Z. Oren, and Y. Shai Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study Biochemistry 36 1997 1826 1835 (Pubitemid 27086279)
27. H.D. Herce, and A.E. Garcia Molecular dynamics simulations suggest a mechanism for translocation of the HIV-1 TAT peptide across lipid membranes Proc. Natl. Acad. Sci. USA 104 2007 20805 20810
28. H.D. Herce, A.E. Garcia, J. Litt, R.S. Kane, P. Martin, N. Enrique, A. Rebolledo, and V. Milesi Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides Biophys. J. 97 2009 1917 1925
29. V. Tiriveedhi, and P. Butko A fluorescence spectroscopy study on the interactions of the Tat-PTD peptide with model lipid membranes Biochemistry 46 2007 3888 3895 (Pubitemid 46493489)
30. A. Ziegler, X.L. Blatter, A. Seelig, and J. Seelig Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis Biochemistry 42 2003 9185 9194 (Pubitemid 36935428)
31. H. Yezid, K. Konate, S. Debaisieux, A. Bonhoure, and B. Beaumelle Mechanism for HIV-1 Tat insertion into the endosome membrane J. Biol. Chem. 284 2009 22736 22746
32. D. Derse, M. Carvalho, R. Carroll, and B.M. Peterlin A minimal lentivirus Tat J. Virol. 65 1991 7012 7015
33. H.K. Avraham, S. Jiang, T.H. Lee, O. Prakash, and S. Avraham HIV-1 Tat-mediated effects on focal adhesion assembly and permeability in brain microvascular endothelial cells J. Immunol. 173 2004 6228 6233 (Pubitemid 39487780)
34. M.E. Garber, P. Wei, V.N. Kewal Ramani, T.P. Mayall, C.H. Herrmann, A.P. Rice, D.R. Littmann, and K.A. Jones The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine cyc T1 protein Genes Dev. 12 1998 3512 3527 (Pubitemid 28553243)
35. A.C. Vendel, and K.J. Lumb Molecular recognition of the human coactivator CBP by the HIV-1 transcriptional activator Tat Biochemistry 42 2003 910 916 (Pubitemid 36159522)
36. S. Shojania, and J.D. O'Neil HIV-1 Tat is a natively unfolded protein J. Biol. Chem. 281 2006 8347 8356
37. J.M. Bigalke, N. Czudnochowski, V. F., K. Vogel-Bachmayr, K. Anand, and M. Geyer Formation of Tat-TAR containing ribonucleoprotein complexes for biochemical and structural analyses Methods 53 2011 78 84
38. A. Mishra, V.D. Gordon, L. Yang, R. Coridan, and G.C.L. Wong HIV Tat forms pores in membranes by inducing saddle-splay curvature: potential role of bidentate hydrogen bonding Angew. Chem. Int. Ed. 47 2008 1 5
39. C. Ciobanasu, J.P. Siebrasse, and U. Kubitscheck Cell-penetrating HIV1 Tat peptides can generate pores in model membranes Biophys. J. 99 2010 153 162
40. P.E.G. Thoren, D. Persson, E.K. Esbjörner, M. Goksör, P. Lincoln, and B. Norden Membrane binding and translocation of cell-penetrating peptides Biochemistry 43 2004 3471 3489 (Pubitemid 38391703)
41. P.E.G. Thoren, D. Persson, P. Lincoln, and B. Norden Membrane destabilizing properties of cell-penetrating peptides Biophys. Chem. 114 2005 169 179 (Pubitemid 40521515)
42. C.E. Caesar, E.K. Esbjörner, P. Lincoln, and B. Norden Membrane interactions of cell-penetrating peptides probed by tryptophan fluorescence and dichroism techniques: correlations of structure to cellular uptake Biochemistry 45 2006 7682 7692 (Pubitemid 43894958)
43. T.H. Tahirov, N.D. Babayeva, K. Varzavand, J.J. Cooper, S.C. Sedore, and D.H. Price Crystal structure of HIV-1 Tat complexed with human P-TEFb Nature 465 2010 747 753
44. G. Schwarz, R. Zong, and T. Popescu Kinetics of melittin induced pore formation in the membrane of lipid vesicles Biochim. Biophys. Acta 1110 1992 97 104
45. G. Schwarz, and A. Arbuzova Pore kinetics reflected in the dequenching of a lipid vesicle entrapped fluorescent dye Biochim. Biophys. Acta 1239 1995 51 57
46. C. Ciobanasu, E. Harms, G. Tünnemann, C.M. Cardoso, and U. Kubitscheck Cell-penetrating HIV-1 Tat peptides float on model lipid bilayers Biochemistry 48 2009 4728 4737
47. P. Curnow, H. Mellor, D.J. Stephens, M. Lorch, and P.J. Booth Translocation of the cell-penetrating Tat peptide across artificial bilayers and into living cells Biochem. Soc. Symp. 72 2005 199 209 (Pubitemid 44804746)
48. N. Umezawa, M.A. Gelman, M.C. Haigis, R.T. Raines, and S.H. Gellman Translocation of a beta-peptide across cell membranes J. Am. Chem. Soc. 124 2002 368 369 (Pubitemid 34084120)
49. S.D. Krämer, and H. Wunderli-Allenspach No entry for Tat (44-57) into liposomes and intact MDCK cells: novel approach to study membrane permeation of cell-penetrating peptides Biochim. Biophys. Acta 1609 2003 161 169 (Pubitemid 36120723)
50. P. Bayer, M. Kraft, A. Ejchart, M. Westendorp, R. Frank, and P. Rösch Structural studies of HIV-1 Tat protein J. Mol. Biol. 247 1995 529 535
51. K. Anand, A. Schulte, K. Vogel-Bachmayr, K. Scheffzek, and M. Geyer Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV Nat. Struct. Mol. Biol. 15 2008 1287 1292
52. J.D. Puglisi, S. Chen, S. Blanchard, and R. Frank Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex Science 270 1995 1200 1203
53. X. Ye, R.A. Kumar, and D.J. Patel Molecular recognition on the bovine immunodeficiency virus Tat peptide-TAR RNA complex Chem. Biol. 2 1995 827 840 (Pubitemid 3014706)
54. G. Tosi, R. Meazza, A. de Lerma Barbaro, A. D'Agostino, S. Mazza, G. Corradin, A. Albini, D.M. Noonan, S. Ferrini, and R.S. Accolla Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR Eur. J. Immunol. 30 2000 1120 1126 (Pubitemid 30216229)